High-Sensitivity Flow Cytometry for the Reliable Detection of Measurable Residual Disease in Hematological Malignancies in Clinical Laboratories
The proposed protocol would allow clinical flow cytometry laboratories to perform MRD studies in house and easily achieve a limit of detection and limit of quantification <0.001%, thus avoiding the need to outsource analysis to specialized cytometry laboratories.
Authors
- María Beatriz Álvarez Flores (ORCID: https://orcid.org/0000-0002-0292-5010)
- Fernando Cava Valenciano
- M Sopena (ORCID: https://orcid.org/0000-0002-8088-279X)
- Raquel Guillén (ORCID: https://orcid.org/0000-0003-0714-5424)
Institutions
- Spanish National Centre for Cardiovascular Research (ES)
- Hospital Universitario Infanta Sofía (ES)
Publication Details
- Journal
- Diseases
- Published
- 2024-12-22
- DOI
- https://doi.org/10.3390/diseases12120338
- Citations
- 2
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Centro Nacional de Investigaciones Cardiovasculares